Regulated Expression and Role of c-Myb in the Cardiovascular-Directed Differentiation of Mouse Embryonic Stem Cells
- 20 January 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 110 (2) , 253-264
Abstract
Rationale:: c-myb null (knockout) embryonic stem cells (ESC) can differentiate into cardiomyocytes but not contractile smooth muscle cells (SMC) in embryoid bodies (EB). Objective:: To define the role of c-Myb in SMC differentiation from ESC. Methods and Results:: In wild-type (WT) EB, high c-Myb levels on days 0–2 of differentiation undergo ubiquitin-mediated proteosomal degradation on days 2.5–3, resurging on days 4–6, without changing c-myb mRNA levels. Activin-A and bone morphogenetic protein 4–induced cardiovascular progenitors were isolated by FACS for expression of vascular endothelial growth factor receptor (VEGFR)2 and platelet-derived growth factor receptor (PDGFR)α. By day 3.75, hematopoesis-capable VEGFR2+ cells were fewer, whereas cardiomyocyte-directed VEGFR2+/PDGFRα+ cells did not differ in abundance in knockout versus WT EB. Importantly, highest and lowest levels of c-Myb were observed in VEGFR2+ and VEGFR2+/PDGFRα+ cells, respectively. Proteosome inhibitor MG132 and lentiviruses enabling inducible expression or knockdown of c-myb were used to regulate c-Myb in WT and knockout EB. These experiments showed that c-Myb promotes expression of VEGFR2 over PDGFRα, with chromatin immunopreciptation and promoter-reporter assays defining specific c-Myb–responsive binding sites in the VEGFR2 promoter. Next, FACS-sorted VEGFR2+ cells expressed highest and lowest levels of SMC- and fibroblast-specific markers, respectively, at days 7–14 after retinoic acid (RA) as compared with VEGFR2+/PDGFRα+ cells. By contrast, VEGFR2+/PDGFRα+ cells cultured without RA beat spontaneously, like cardiomyocytes between days 7 and 14, and expressed cardiac troponin. Notably, RA was required to more fully differentiate SMC from VEGFR2+ cells and completely blocked differentiation of cardiomyocytes from VEGFR2+/PDGFRα+ cells. Conclusions:: c-Myb is tightly regulated by proteosomal degradation during cardiovascular-directed differentiation of ESC, expanding early-stage VEGFR2+ progenitors capable of RA–responsive SMC formation.Keywords
This publication has 43 references indexed in Scilit:
- TIF1β regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent mannerProceedings of the National Academy of Sciences, 2010
- miR-10a Contributes to Retinoid Acid-induced Smooth Muscle Cell DifferentiationJournal of Biological Chemistry, 2010
- Conditional c- myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiationProceedings of the National Academy of Sciences, 2009
- Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cellsProceedings of the National Academy of Sciences, 2007
- Biphasic role for Wnt/β-catenin signaling in cardiac specification in zebrafish and embryonic stem cellsProceedings of the National Academy of Sciences, 2007
- Regulation of myosin light chain kinase and telokin expression in smooth muscle tissuesAmerican Journal of Physiology-Cell Physiology, 2006
- The Wnt/β-catenin pathway regulates cardiac valve formationNature, 2003
- Hematopoietic cells in cultures of the murine embryonic aorta–gonad–mesonephros region are induced by c-MybCurrent Biology, 1999
- Differential Response of Mesoderm- and Neural Crest-Derived Smooth Muscle to TGF-β1: Regulation of c-myb and α1 (I) Procollagen GenesExperimental Cell Research, 1997
- A functional c-myb gene is required for normal murine fetal hepatic hematopoiesisCell, 1991